Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.
A*STAR researchers have discovered that thin-walled metallic parts built via additive manufacturing are weaker than expected, initiating a search for solutions
Regular disinfection can help to limit the spread of viral infections such as COVID-19, but only if carried out appropriately, write Xian Jun Loh and colleagues.
Antiviral strategies against COVID-19 broadly fall into two groups: those that target the virus and those that target the host factors that are essential for virus replication.
Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.
Page
Get the PDF delivered to your inbox.
By entering your email, you also agree to be added to the A*STAR Research mailing list.
Get the PDF delivered to your inbox.
By entering your email, you also agree to be added to the A*STAR Research mailing list.
Join our mailing list
Stay up to date with the latest research highlights from A*Star.